Before the anti-cyclin D1 antibody was widely available as a powerful tool to help distinguish MCL from CLL by flow cytometry, CD23 status had been considered very useful in separating CLL from MCL, especially when CD23 is either moderately. Here, CCND1 is linked to B-cell chronic lymphocytic leukemia.